Delivery Order 36F79724D0119-36C24525N0552

Award Date 4/9/25
Potential Completion Date 4/10/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Department of Veterans Affairs (VA) to Insmed Inc., a global biopharmaceutical company, for the provision of emergency pharmacy orders. The order, valued at $70,737.80, is for firm fixed-price pharmaceutical products to be delivered by September 30, 2025. The contract is not set aside for any particular business type. Insmed Inc. holds multiple federal contract vehicles with the VA, including a GSA Pharmaceutical and Drugs schedule contract, which...
The Department of Veterans Affairs Veterans Health Administration awarded Insmed Incorporated a $53,550.49 delivery order against its Pharmaceuticals and Drugs GSA Schedule to provide emergency supplies of the antibiotic amikacin through December 2023. As the prime contractor, Insmed will deliver the drug from its Carrollton, Texas facility to support VHA's efforts through Veterans Integrated Service Network 22. Insmed will perform on a firm-fixed-price basis over the six-month ordering...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ARIKAYCE 590 MG/8.4 ML VIAL 8.4ML, a specialty pharmaceutical product. The contract has a ceiling value of $15,308.51 and runs through October 9, 2024. This appears to be a task order or delivery order off a larger Indefinite Delivery Contract (IDC) vehicle held by...
This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 5, a civilian agency under the Department of Veterans Affairs, to Insmed Inc. for the drug BELZUTIFAN (WELIREG) 40 MG. The contract has a ceiling value of $10,105.41 and a completion date of February 17, 2025. Insmed Inc. is a global biopharmaceutical company that provides pharmaceuticals and drugs to the VA, including the antibiotic amikacin and the drug ARIKAYCE for the treatment of nontuberculous...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to Actelion Pharmaceuticals US, Inc., a for-profit pharmaceutical manufacturer. The $81,739.77 firm fixed-price delivery order is for the supply of Ventavis (iloprost) 10 mcg/mL inhalation solution, an oral medication used to treat pulmonary arterial hypertension. The contract is part of a larger Indefinite Delivery Vehicle (IDV) under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call issued by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 7 (VISN 7) to Ariad Pharmaceuticals, Inc. for the order of pharmaceuticals, specifically cancer drugs such as Iclusig (ponatinib) and Lenvima (lenvatinib), for the Department of Veterans Affairs in fiscal year 2017. The contract has a ceiling value of $108,039.90 and an ultimate completion date of September 30, 2017. This contract was awarded...
This is a federal contract award to Acorda Therapeutics, Inc., a biotechnology company that specializes in the development and commercialization of therapies for neurological disorders. The contract, valued at $861,948.00, is for the supply of open market pharmaceuticals to the Department of Veterans Affairs (VA) Hines Community-Based Outpatient Pharmacy (CMOP). The contract is a delivery order under Acorda's Federal Supply Schedule (FSS) contract with the VA, which is valued at over $16.3...
This federal contract award is for the delivery of pharmaceutical products to the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 6 (VISN 6). The prime contractor, United Therapeutics Corp, is a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract, valued at $90,364.00, is a delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,941.36 firm fixed-price delivery order is for the pharmaceutical product INBRIJA 42 MG INHALATION CAP 60S. The contract has an ultimate completion date of January 27, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This delivery order contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Ariad Pharmaceuticals, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is for the delivery of prescription medications, specifically the cancer drugs Iclusig (ponatinib) and Lenvima (lenvatinib), to VA hospitals and medical centers. The contract has a firm fixed price with a potential value of $138,026.40 and was placed under the General Services...
  • 36F79724D0119
    Federal Supply Schedule
  • 36F79724D0119-36C24525N0552
    Delivery Order

This federal contract award was issued by the Veterans Integrated Service Network 5 (VISN 5), a civilian agency under the U.S. Department of Veterans Affairs (VA), to Insmed Inc. The $10,105.40 firm fixed-price delivery order is for the supply of ARIKAYCE (amikacin) 590mg/8.4ml, a pharmaceutical product used to treat non-tuberculous mycobacterial lung infections in veterans.

The contract has no set-aside designation and is part of Insmed's existing federal supply schedule contract with the VA for pharmaceuticals and drugs. Insmed, a global biopharmaceutical company, has provided ARIKAYCE and other critical medications to VA medical centers under this and other federal contract vehicles. The contract has an ultimate completion date of April 10, 2025.

Generated 4/13/25, 12:47 AM